AMA CPT® Assistant - 2021 Issue 1 (January)
New COVID-19 Vaccine Codes: January Update (January 2021)
January 2021 Special Edition New COVID-19 Vaccine Codes: January Update New Current Procedural Terminology (CPT®) codes for a new vaccine product from Janssen and its administration have been added to the previously established vaccine codes for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (coronavirus disease 2019 [COVID-19]). The CPT Editorial Panel has approved the latest vaccine product code, which will become effective upon receiving the Emergency Use Authorization (EUA) or approval from the Food and Drug Administration (FDA). In order to assist CPT code users in differentiating and appropriately reporting the available vaccine product codes and their affiliated...
Subscribe or sign in to view the full article.
Article Overview
This January 2021 CPT Assistant special edition covers updates to COVID-19 vaccine coding, focusing on newly added vaccine product and administration codes, related Appendix Q changes, and supporting guidance for reporting vaccine services. It is aimed at coders, billers, and clinical documentation teams who need to understand how the CPT COVID-19 vaccine code set was being expanded and organized at that time. The article also references the AMA’s ongoing update resources and includes clinical examples and procedure descriptions illustrating typical vaccination scenarios.
Why This Topic Matters
COVID-19 vaccine coding changed rapidly during rollout, and this update documents a new CPT vaccine product entry, its administration counterpart, and the supporting structure used to keep vaccine reporting current. It helps readers understand where to look for official CPT guidance and how the evolving COVID-19 vaccine code set was being maintained.
Article Sections
-
January 2021 Special Edition
Introduces the update and places it within the January 2021 special edition context.
-
Immunization Administration for Vaccines/Toxoids
Summarizes general immunization administration content relevant to vaccine reporting and related CPT guidance.
-
Vaccines, Toxoids
Presents the newly discussed vaccine product content and its relationship to associated administration reporting.
-
Clinical Example (91303) / Description of Procedure (91303)
Provides a typical scenario and procedure narrative associated with the vaccine product example.
-
Clinical Example (0031A) / Description of Procedure (0031A)
Provides a typical scenario and procedure narrative associated with the administration code example.
What You Will Learn
- The scope of the January 2021 CPT COVID-19 vaccine coding update
- How the article organizes vaccine product and administration guidance
- What supporting CPT resources are referenced for COVID-19 vaccine reporting
- How the article frames clinical examples and procedure descriptions for the new vaccine code structure
- What appendix-related changes are mentioned for vaccine coding reference
Who Should Read This
- Medical coders
- Billing staff
- Clinical documentation specialists
- Practice managers
- Immunization program staff
Codes Discussed
Code Ranges Discussed
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com
